Skip to content

Exercise Training in Chagas Cardiomyopathy

A Randomized Trial of the Effects of Exercise Training in Chagas Cardiomyopathy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01006473
Enrollment
37
Registered
2009-11-02
Start date
2007-03-31
Completion date
2009-03-31
Last updated
2015-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathy, Chagas Disease, Exercise Training

Keywords

Chagas Disease, Chagas Cardiomyopathy, Exercise Movement Techniques

Brief summary

The benefits of exercise training in heart failure are well established. Its effects, however, have not been evaluated in Chagas cardiomyopathy (ChC). The investigators hypothesis is that the exercise training may improve functional capacity, quality of life (QoL), and reduce brain natriuretic peptide (BNP) levels in patients with ChC.

Interventions

OTHERExercise training

Sponsors

Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Chronic Chagas dilated cardiomyopathy, defined by the echocardiography finding of a dilated left ventricle with moderate or severe impaired left ventricular systolic function (left ventricular ejection fraction ≤ 45%). * To be clinically stable for at least 3 months * To have sinus rhythm * To be under standard medical therapy use at the time.

Exclusion criteria

* Inability to attend regular exercise training * The presence of a pacemaker, associated cardiac or systemic diseases * Practitioners of regular physical activity

Design outcomes

Primary

MeasureTime frame
Functional capacity12 weeks
Functional class12 weeks
Health related quality of life12 weeks
BNP levels12 weeks

Secondary

MeasureTime frame
Complications related to the exercise training12 weeks

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026